209 related articles for article (PubMed ID: 16689182)
1. Biological standardization and maximum tolerated dose estimation of an Alternaria alternata allergenic extract.
Lizaso MT; Martínez A; Asturias JA; Algorta J; Madariaga B; Labarta N; Tabar AI
J Investig Allergol Clin Immunol; 2006; 16(2):94-103. PubMed ID: 16689182
[TBL] [Abstract][Full Text] [Related]
2. Preclinical safety and immunological efficacy of Alternaria alternata polymerized extracts.
Morales M; Gallego MT; Iraola V; Moya R; Santana S; Carnés J
Immun Inflamm Dis; 2018 Jun; 6(2):234-244. PubMed ID: 29265735
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of Alternaria alternata sensitization with natural and recombinant Alt a 1 allergens.
Asturias JA; Ibarrola I; Ferrer A; Andreu C; López-Pascual E; Quiralte J; Florido F; Martínez A
J Allergy Clin Immunol; 2005 Jun; 115(6):1210-7. PubMed ID: 15940136
[TBL] [Abstract][Full Text] [Related]
4. A sensitive two-site enzyme-linked immunosorbent assay for measurement of the major Alternaria alternata allergen Alt a 1.
Asturias JA; Arilla MC; Ibarrola I; Eraso E; González-Rioja R; Martínez A
Ann Allergy Asthma Immunol; 2003 May; 90(5):529-35. PubMed ID: 12775134
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, placebo-controlled Alternaria alternata immunotherapy: in vivo and in vitro parameters.
Lizaso MT; Tabar AI; García BE; Gómez B; Algorta J; Asturias JA; Martínez A
Pediatr Allergy Immunol; 2008 Feb; 19(1):76-81. PubMed ID: 17662037
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy with an oral Alternaria extract in childhood asthma. Clinical safety and efficacy and effects on in vivo and in vitro parameters].
Criado Molina A; Guerra Pasadas F; Daza Muñoz JC; Moreno Aguilar C; Almeda Llamas E; Muñoz Gomariz E; Font Ugalde P; Alonso Díaz C; Germán Cárdenas M; Sánchez Guijo P
Allergol Immunopathol (Madr); 2002; 30(6):319-30. PubMed ID: 12464165
[TBL] [Abstract][Full Text] [Related]
7. Expression of Alt a 1 allergen from Alternaria alternata in the yeast Yarrowia lipolytica.
Morín M; Asturias JA; Domínguez A
FEMS Microbiol Lett; 2012 Aug; 333(2):121-8. PubMed ID: 22640235
[TBL] [Abstract][Full Text] [Related]
8. Specific IgE against Alternaria alternata in atopic dermatitis and asthma patients.
Hedayati MT; Arabzadehmoghadam A; Hajheydari Z
Eur Rev Med Pharmacol Sci; 2009; 13(3):187-91. PubMed ID: 19673169
[TBL] [Abstract][Full Text] [Related]
9. IgE-mediated allergy to fungal allergens in Finland with special reference to Alternaria alternata and Cladosporium herbarum.
Reijula K; Leino M; Mussalo-Rauhamaa H; Nikulin M; Alenius H; Mikkola J; Elg P; Kari O; Mäkinen-Kiljunen S; Haahtela T
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):280-7. PubMed ID: 14533661
[TBL] [Abstract][Full Text] [Related]
10. Alternaria alternata allergens: Markers of exposure, phylogeny and risk of fungi-induced respiratory allergy.
Gabriel MF; Postigo I; Tomaz CT; Martínez J
Environ Int; 2016; 89-90():71-80. PubMed ID: 26826364
[TBL] [Abstract][Full Text] [Related]
11. Correlation between Alt a 1 levels and clinical symptoms in Alternaria alternata-monosensitized patients.
Feo Brito F; Alonso AM; Carnés J; Martín-Martín R; Fernández-Caldas E; Galindo PA; Alfaya T; Amo-Salas M
J Investig Allergol Clin Immunol; 2012; 22(3):154-9. PubMed ID: 22697004
[TBL] [Abstract][Full Text] [Related]
12. Specific Antibodies for the Detection of Alternaria Allergens and the Identification of Cross-Reactive Antigens in Other Fungi.
Twaroch TE; Curin M; Sterflinger K; Focke-Tejkl M; Swoboda I; Valenta R
Int Arch Allergy Immunol; 2016; 170(4):269-278. PubMed ID: 27780168
[TBL] [Abstract][Full Text] [Related]
13. Production profile of the major allergen Alt a 1 in Alternaria alternata cultures.
Ibarrola I; Suárez-Cervera M; Arilla MC; Martínez A; Monteseirín J; Conde J; Asturias JA
Ann Allergy Asthma Immunol; 2004 Dec; 93(6):589-93. PubMed ID: 15609770
[TBL] [Abstract][Full Text] [Related]
14. Carrier-bound Alt a 1 peptides without allergenic activity for vaccination against Alternaria alternata allergy.
Twaroch TE; Focke M; Fleischmann K; Balic N; Lupinek C; Blatt K; Ferrara R; Mari A; Ebner C; Valent P; Spitzauer S; Swoboda I; Valenta R
Clin Exp Allergy; 2012 Jun; 42(6):966-75. PubMed ID: 22909168
[TBL] [Abstract][Full Text] [Related]
15. Variability of Alt a 1 expression by different strains of Alternaria alternata.
Martínez J; Gutiérrez A; Postigo I; Cardona G; Guisantes J
J Investig Allergol Clin Immunol; 2006; 16(5):279-82. PubMed ID: 17039665
[TBL] [Abstract][Full Text] [Related]
16. Alt a 15 is a new cross-reactive minor allergen of Alternaria alternata.
Gabriel MF; Postigo I; Gutiérrez-Rodríguez A; Suñén E; Guisantes JA; Fernández J; Tomaz CT; Martínez J
Immunobiology; 2016 Feb; 221(2):153-60. PubMed ID: 26395961
[TBL] [Abstract][Full Text] [Related]
17. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
18. Antigenic and allergenic cross-reactivity of Epicoccum nigrum with other fungi.
Bisht V; Singh BP; Arora N; Gaur SN; Sridhara S
Ann Allergy Asthma Immunol; 2002 Sep; 89(3):285-91. PubMed ID: 12269649
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
Rossi RE; Monasterolo G
Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of specific immunotherapy with standardized allergenic extracts adsorbed on aluminium hydroxide.
Wüthrich B; Gumowski PL; Fäh J; Hürlimann A; Deluze C; André C; Fadel R; Carat F
J Investig Allergol Clin Immunol; 2001; 11(3):149-56. PubMed ID: 11831445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
